·乌司奴单抗是否可以成为CD患者生物制剂一线首选？

·Can ustekinumab become the first-line first-line biologics for CD patients?

11:50-12:10

专场2 (Channel 2)

杨森卫星会

讲者 (Speaker)

·站在病程转折点改写中度克罗恩病患者的治疗结局

·Rewriting Treatment Outcomes for Patients with Moderate Crohn's Disease at a Turning Point in the Disease Course

15:20-15:40

专场2 (Channel 2)

武田卫星会

讲者 (Speaker)

·小分子药物在UC中的研究进展

·Research progress of small molecule drugs in UC.

20:50-21:10

专场2 (Channel 2)

炎症性肠病

Inflammatory Bowel Disease

讲者 (Speaker)